I1DX34:BVMF
Idexx Laboratories Inc Bdr
531,51 BRL
0,00%
(0,00) 1D
14-окт., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for I1DX34...
Open
531,51 BRL
High
531,51 BRL
Low
531,51 BRL
Mkt. cap
41,68 млд
Avg. vol.
6,00
Volume
1,00
52-wk high
813,60 BRL
52-wk low
509,99 BRL
Shares outstanding
78,78 млн
No. of employees
11 миң
Open
531,51 BRL
High
531,51 BRL
Low
531,51 BRL
Mkt. cap
41,68 млд
Avg. vol.
6,00
Volume
1,00
52-wk high
813,60 BRL
52-wk low
509,99 BRL
Shares outstanding
78,78 млн
No. of employees
11 миң
News stories
From web sources and news partners
Yahoo Finance
·
7 саат мурун
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts
Simply Wall Street
·
20 саат мурун
IDEXX Laboratories (IDXX) Stock May Be 12% Undervalued Despite AI Acquisition
Investing.com
·
2 күн мурун
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight
Profile
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
About Idexx Laboratories Inc Bdr
CEOJay Mazelsky
Employees11 миң
Founded1983-ж., 19-дек.
HeadquartersУэстбрук, Мэн, Америка Кошмо Штаттары
SectorMedical device
Websiteidexx.com